| Back To Wellness Plc | |
|
368 Dorset St Ste 3 South Burlington VT 05403-6236 | |
| (802) 864-4959 | |
| (802) 864-4959 |
| Full Name | Back To Wellness Plc |
|---|---|
| Speciality | Clinic/Center |
| Location | 368 Dorset St Ste 3, South Burlington, Vermont |
| Authorized Official Name and Position | Heather Lynn Diederich (OWNER) |
| Authorized Official Contact | 8024346669 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Back To Wellness Plc 368 Dorset St Ste 3 South Burlington VT 05403-6236 Ph: (802) 864-4959 | Back To Wellness Plc 368 Dorset St Ste 3 South Burlington VT 05403-6236 Ph: (802) 864-4959 |
| NPI Number | 1912211210 |
|---|---|
| Provider Enumeration Date | 07/29/2010 |
| Last Update Date | 09/21/2011 |
| Medicare PECOS PAC ID | 4981876349 |
|---|---|
| Medicare Enrollment ID | O20111006000263 |
News Archive
The Chronic Fatigue Initiative (CFI) - a new privately funded research directive focused on chronic fatigue syndrome - announced a substantial grant to a Columbia University research team to investigate the role of pathogens in causing chronic fatigue syndrome. The pathogen discovery and pathogenesis program will be led by Drs. Ian Lipkin and Mady Hornig of the Center for Infection and Immunity.
An antiviral drug that inhibits a virus' replication machinery selectively targets the most aggressive viruses, according to new research that looked at the infection of individual cells by a virus and the consequence of antiviral intervention.
CE Mark has been awarded to the new rotating thumbwheel deployment system for Cook Medical's Zilver PTX drug-eluting peripheral stent. The new system, which is now available for purchase in the UK, Ireland, Germany, Spain and Italy, provides simple deployment for the world's first and only approved drug-eluting stent for the superficial femoral artery (SFA).
In a study appearing in the October 4 issue of JAMA, Paul S. Chan, M.D., of Saint Luke's Mid America Heart Institute, Kansas City, and colleagues evaluated the association of hypothermia treatment with survival to hospital discharge and with favorable neurological survival at hospital discharge among patients with in-hospital cardiac arrest.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912211210 | NPI | - | NPPES |
| VN1626 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | 006-0000998 (Vermont) | Primary |
| Provider Name | Heather L Diederich |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1326101080 PECOS PAC ID: 3870765233 Enrollment ID: I20111006000293 |
News Archive
The Chronic Fatigue Initiative (CFI) - a new privately funded research directive focused on chronic fatigue syndrome - announced a substantial grant to a Columbia University research team to investigate the role of pathogens in causing chronic fatigue syndrome. The pathogen discovery and pathogenesis program will be led by Drs. Ian Lipkin and Mady Hornig of the Center for Infection and Immunity.
An antiviral drug that inhibits a virus' replication machinery selectively targets the most aggressive viruses, according to new research that looked at the infection of individual cells by a virus and the consequence of antiviral intervention.
CE Mark has been awarded to the new rotating thumbwheel deployment system for Cook Medical's Zilver PTX drug-eluting peripheral stent. The new system, which is now available for purchase in the UK, Ireland, Germany, Spain and Italy, provides simple deployment for the world's first and only approved drug-eluting stent for the superficial femoral artery (SFA).
In a study appearing in the October 4 issue of JAMA, Paul S. Chan, M.D., of Saint Luke's Mid America Heart Institute, Kansas City, and colleagues evaluated the association of hypothermia treatment with survival to hospital discharge and with favorable neurological survival at hospital discharge among patients with in-hospital cardiac arrest.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
› Verified 1 days ago
News Archive
The Chronic Fatigue Initiative (CFI) - a new privately funded research directive focused on chronic fatigue syndrome - announced a substantial grant to a Columbia University research team to investigate the role of pathogens in causing chronic fatigue syndrome. The pathogen discovery and pathogenesis program will be led by Drs. Ian Lipkin and Mady Hornig of the Center for Infection and Immunity.
An antiviral drug that inhibits a virus' replication machinery selectively targets the most aggressive viruses, according to new research that looked at the infection of individual cells by a virus and the consequence of antiviral intervention.
CE Mark has been awarded to the new rotating thumbwheel deployment system for Cook Medical's Zilver PTX drug-eluting peripheral stent. The new system, which is now available for purchase in the UK, Ireland, Germany, Spain and Italy, provides simple deployment for the world's first and only approved drug-eluting stent for the superficial femoral artery (SFA).
In a study appearing in the October 4 issue of JAMA, Paul S. Chan, M.D., of Saint Luke's Mid America Heart Institute, Kansas City, and colleagues evaluated the association of hypothermia treatment with survival to hospital discharge and with favorable neurological survival at hospital discharge among patients with in-hospital cardiac arrest.
Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder (ADHD) and the potential for increased risk of heart attack, stroke or other cardiovascular problems.
› Verified 1 days ago
Frank Landry Md Plc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 43 Timber Ln, South Burlington, VT 05403 Phone: 802-860-3940 Fax: 802-497-0511 | |
Samuel R. Stoyak, M.d., Plc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 43 Timber Ln, South Burlington, VT 05403 Phone: 802-448-3759 | |
Megan P Malgeri Md Pllc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 43 Timber Ln, South Burlington, VT 05403 Phone: 802-448-3759 Fax: 802-497-2472 | |
Get Well Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3000 Williston Rd, South Burlington, VT 05403 Phone: 802-660-3110 Fax: 802-860-4396 | |
Concentra Medical Centers Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 57 Fayette Dr Unit 1, South Burlington, VT 05403 Phone: 802-658-5756 Fax: 802-865-0042 | |
Goodhealth P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 368 Dorset St, Suite 1, South Burlington, VT 05403 Phone: 802-860-1441 | |
Mindful Counseling And Massage Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 359 Dorset St Ste 200, South Burlington, VT 05403 Phone: 802-503-5545 |